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INTRODUCTION/OBJECTIVES: We determined the degree of risk produced by the association of other surgical procedures with 
surgical myocardial revascularization in octogenarian patients and identified the risk factors that best explain hospital mortality. 
METHODS: This study was an observational analytical historical cohort study involving octogenarians operated on at our institution 
between January 1, 2000 and January 1, 2005. We stratified the objective population as follows: Group 1 comprised octogenarians 
revascularized without associated procedures, and Group 2 comprised octogenarians revascularized with associated procedures. 
Statistical analyses included the t test for independent samples and multiple logistic regression analysis. Significance was accepted 
with an alpha error of 5%. 
RESULTS: Univariate analyses revealed the following clinical and statistically significant variables: hospital mortality (P=0.002), 
diabetes mellitus (P=0.017), preoperative endocarditis (P=0.001), cardiogenic shock (P=0.019), use of an intra-aortic balloon pump 
(P=0.026), preoperative risk score (Parsonnet), P<0.001, procedure associated with revascularization (P<0.001), medium number 
of affected coronary arteries (P<0.001), use of extracorporeal circulation (P<0.001), time of extracorporeal circulation (P<0.001), 
number of distal anastomoses (P=0.002), graft type (P<0.001), postoperative breathing support (P<0.001), stroke (P<0.001), infec-
tion (P=0.002), creatinine level (P=0.018), and quality of life score (P=0.050). 
DISCUSSION/CONCLUSIONS: In octogenarian patients, the need for a procedure associated with surgical myocardial revascu-
larization produces an absolute increase in hospital mortality risk of 45%. The variables that contributed to hospital mortality were 
preoperative endocarditis, preoperative cardiogenic shock, the use of extracorporeal circulation, the length of time of extracorporeal 
circulation, postoperative creatinine level, and postoperative need for prolonged respiratory support. 
KEYWORDS: Myocardial revascularization; Coronary artery bypass; Aged, 80 and over; Coronary artery bypass, Off pump; 
Aged groups.
INTRODUCTION 
Jones et al.1 analyzed 799 patients undergoing primary 
elective aortic valve replacement associated with myocardial 
revascularization between March 1986 and May 2000, 
and affirmed that the treatment of coronary artery disease 
combined with aortic valve replacement improves clinical 
outcomes; however, when survival was compared with isolated 
valve replacement, the outcome remained uncertain, as did 
the use of the left thoracic internal mammary artery (LIMA) 
graft for the left anterior descending (LAD) branch. Multiple 
regression analyses identified the following as independent 
predictors of decreased survival: advanced age (P<0.001), 
female sex (P<0.001), absence of diabetes (P=0.02), the 
number of grafts in the operation (P=0.04), absence of 
congenital valve disease (P=0.001), and valve insufficiency 
(P=0.008). The effect of the LIMA-LAD coronary graft was 
not significant based on multivariate analyses. 
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Nwakanma et  a l . 2 concluded that  combined 
surgical treatment for carotid arteries and myocardial 
revascularization does not increase mortality and morbidity 
in short- and long-term follow-up when compared with 
isolated revascularization. The late follow-up data included 
myocardial infarction, stroke, and death. No statistical 
differences were noted between groups regarding the 
outcomes of death, stroke, and myocardial infarction in the 
60-month follow-up (P>0.05). 
Woo et al.3 reported that left ventricular dysfunction is an 
independent predictor of morbidity and hospital mortality in 
myocardial revascularization accomplished with the aid of 
extracorporeal circulation, and that completing the procedure 
without extracorporeal circulation support represents an 
effective and safe way to treat patients with significant left 
ventricular dysfunction.
Sirivella4 et al. analyzed 468 patients who underwent 
concomitant mitral valve and coronary artery surgeries and 
identified the following as predictors of hospital mortality: 
severe coronary disease, prior acute myocardial infarction, 
low ejection fraction, ischemic mitral insufficiency, 
symptoms of advanced heart failure, not using the internal 
thoracic artery, valve substitution, and emergency surgery. 
Jensen et al.5 studied the quality of life related to 
revascularization with and without extracorporeal circulation 
in seniors with moderate- and high-operative risk, and 
reported that quality of life improved in both groups after 
the operation; significant clinical differences did not exist 
between the groups. One exception was improved problem 
solving in patients operated on with the aid of extracorporeal 
circulation (P=0.04). 
Onorati et al.6 analyzed 50 patients with chronic 
obstructive pulmonary disease (COPD) stratified into 
two groups of 25 in order to test the effects of the intra-
aortic balloon on the preservation of lung function. It was 
concluded that the use of the intra-aortic balloon at an 
automated regimen of 80 beats per minute during cardiac 
arrest induced by a cardioplegic solution preserved lung 
function in patients with COPD. 
Biancari et al.7 evaluated the predictive value of 
EuroSCORE for identification of patients at high risk 
for adverse clinical outcomes after heart surgery. It 
was concluded that EuroSCORE represents a relevant 
predictor for immediate and late outcomes after myocardial 
revascularization with extracorporeal circulation. 
Reddy et al.8 examined the effect of extracorporeal 
circulation on patients’ breathing. It was concluded that 
surgery without extracorporeal circulation offers benefits to 
patients with a high respiratory risk by reducing the time of 
postoperative breathing support, and that patients operated 
on without extracorporeal circulation also had smaller 
alveolus-arterial gradients in the immediate postoperative 
period; however, that last result did not reach statistical 
significance. We ourselves have examined results of elective 
vs non-elective radial artery grafts.9
Rankin et al.10 evaluated the risk factors for hospital 
mortality in the surgical treatment of valvulopathy. 
The relevance of the risk factors was based on odds 
ratios. The factors with the greatest significance were 
non-elective surgery (OR=2.11), advanced age (≥ 70 
years) (OR=1.88), re-operation (OR=1.61), endocarditis 
(OR=1.59), and coronary artery disease (OR=1.58). Valve 
substitution compared with valvuloplasty was found to be 
associated with the greatest mortality (OR=1.52). In general, 
improved clinical outcomes were less prevalent in females 
(OR=1.34) during the study period. However, any isolated 
comorbidity, on average, made a moderate contribution to 
the risk (OR=1.19). Specific comorbidities such as renal 
insufficiency or multiple comorbidities in certain patients 
could have significant effects. Reconstruction of the aortic 
arch had the highest risk (OR=2.78) followed by tricuspid 
valve (OR=2.26), multiple valve (OR=2.06), isolated valve 
(OR=1.47), pulmonary valve (OR=1.29), and aortic valve 
procedures. The degree of reduction in the ejection fraction 
and the severity of the valvular lesion were relatively less 
important (OR=1.34 and 0.83, respectively). 
Our study was conducted to identify the risk factors 
for hospital mortality in octogenarian patients who 
underwent procedures associated with surgical myocardial 
revascularization. We also sought to determine the degree 
of risk produced by the association of other surgical 
procedures with surgical myocardial revascularization in 
these patients. 
MATERIALS AND METHODS
This was an observational, analytical study of the 
historical cohort type involving patients operated on at 
our hospital from January 1, 2000 to January 1, 2005. We 
stratified the objective population into the following study 
samples: Group 1 (G1) comprised octogenarian patients 
revascularized without associated procedures, and Group 2 
(G2) comprised octogenarians revascularized with one or 
more associated procedure. Statistical analyses included the 
t test for independent samples followed by multiple logistic 
regression analysis for better adjustment of the model and 
explanation of hospital mortality. Significance was accepted 
for an alpha error of 5%. 
RESULTS 
Univariate analysis was performed on 53 parameters 
389
CLINICS 2009;64(5):387-92 Myocardial revascularization in aged goups
Iglezias JCR et al.
(Table 1) comparing Group 1 with Group 2 (Table 2). 
Although some differences were found in the parameters 
between Groups 1 and 2, not all of these differences were 
statistically significant. Patients included 45 (39.13%) 
females and 70 (60.86%) males in Group 1 and 15 (46.87%) 
females and 17 (53.12%) males in Group 2 (P=0.456). 
Group 1 patients were 82.59±2.05 years of age, and 
Group 2 patients were 83.40±2.63 years of age (P=0.065). 
The hospital stay in G1 was 16.10±15.98 days versus 
18.59±19.77 in G2 (P=0.461).
Diabetes was less prevalent in Group 2 patients 
undergoing associated procedures (12.5% versus 34.8%, 
P=0.017), 
The intra-aortic balloon pump was used in a greater 
percentage of Group 2 patients undergoing associated 
procedures.
Cardiogenic shock was greater in the Group 2 patients 
undergoing associated procedures than in Group 1 patients 
(22.6% versus 7.8%, P=0.019). Preoperative endocarditis 
was more prevalent in Group 2 than in Group 1 patients 
(15.6% versus 1.7%, P=0.001). All-cause hospital mortality 
was greater in Group 2. 
We observed a larger number of arteries affected by 
coronary artery disease in Group 1 patients who did not 
undergo associated procedures (2.59±0.67 versus 2.06±0.71, 
P<0.001). 
Extracorporeal circulation was used in a greater 
percentage of Group 2 patients (100% versus 57%, 
P<0.001).
The time of extracorporeal circulation was longer 
in Group 2 patients (122.37±35.12 versus 52.37±52.78, 
P<0.001) as was the clamp time for the aorta (88.92±26.24 
versus 32.70±34.76, P<0.001). 
The number of distal grafts was smaller in Group 2 
than in Group 1 patients (2.08±0.80 versus 2.57±0.89, 
P=0.002).
Considering the type of graft used, pure (vein only) or 
combined arterial grafts (only artery or artery and vein) were 
used in a greater number of Group 1 patients (68.5% versus 
23.3%, P<0.001). 
Parsonnet preoperative risk scores were higher in Group 
2 than in Group 1 patients (33±8.33 versus 24.12±8.39, 
P<0.001). 
A larger percentage of Group 2 than Group 1 patients 
had elevated postoperative creatinine levels (3.1% versus 
1.7%, P=0.018). 
Group 2 had the largest percentage of postoperative 
stroke (21.9% versus 3.5%, P<0.001). 
The need for breathing support at 24 hours was greater 
in Group 2 than in Group 1 patients (53.12% versus 19.1%, 
P<0.001). 
Table 1 - Characterization of the groups
Variables G1  CABG with-
out AP
G2  CABG with 
AP
 P Value
Nº. of patients 115 32
Age 82,59 ± 2,18 83,40 ± 2,63 0,513
Sex 0,456
   Male 70(60,86%) 17(53,12%)
   Female 45(39,13%) 15(46,87%)
Weight 68,40 ± 10,56 64,21 ± 10,87 0,066
Height 1,62 ± 0,08 1,59 ± 0,09 0,193
Body mass index 26,01 ± 3,50 25,07 ± 3,28 0,202
Diabetes 0,017
   No 74(64,3%) 27(84,4%)
   Yes 40(34,8%) 4(12,5%)
Card. shock. preop. 0,019
   No 106(97,2%) 24(77,4%)
   Yes 9(2,8%) 7(22,6%)
Int.aort.balloon préop. 0,026
   No 108(93,9%) 26(81,3%)
   Yes 7(6,1%) 6(18,8%)
Preop. Endocarditis 0,001
   No 113(98,3%) 27(84.4%)
   Yes 2(1,7%) 5(15,6%)
Preop. score of risk  
(Parsonnet)
24,12 ± 8,39 33,00 ± 8,33 0,000
Nº. damaged arteries 2,59 ± 0,67 2,06 ± 0,71 0,000
Extracorporeal use 0,000
   No 66(57,39%) 0,0(0,0%)
   Yes 49(42,6%) 32(100%)
Time of extracorporeal 52,37 ± 52,78 122,37 ± 35,12 0,000
Aortic clamping time 32,70 ± 34,76 88,92 ± 26,24 0,000
Nº  distal anastomosis 2,57 ± 0,89 2,0 ± 0,80 0,002
Graft type 0,000
Arterial or mixed 78(68,5%) 8(23,3%)
Venuos 37(31,5%) 24(76,7%)
Breath supp. .≥ 24hs 0,000
   No 93(80,9%) 15(46,87%)
   Yes 22(19,1%) 17(53,12%)
Posop. creatinine 0,018
   No 102(88,7%) 23(71,9%)
   Yes 13(11,3%) 9(28,1%)
Posop. infection 0,002
   No 77(67,3%) 12(37,5%)
   Yes 38(32,7%) 20(62,5%)
Preop qual. of life 0,050
Good; light restrict 64(55,6%) 11(33,3%)
Mod; imp. restrict 51(44,4%) 21(66,7%)
Death 0,002
   No 102(88,69%) 14(43,75%)
   Yes 13(11,30%) 18(56,25%)
AP= Associated procedure
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When we analyzed postoperative infection with or 
without systemic repercussions, we observed a higher 
incidence in Group 2 than in Group 1 patients (37% versus 
32.7%, P=0.002). Infections with systemic repercussions 
or with mediastinitis occurred in <2% of patients in both 
groups. 
Postoperative quality of life was significantly improved 
for both groups; however, it was greater in Group 1 patients 
(55.6% versus 33.3%, P=0.050). 
Hospital mortality was greater in Group 2 than in Group 1 
patients. We lost 18 patients in Group 2 and 13 in Group 1. 
DISCUSSION 
Our findings do not confirm those of Jones et al.1 
regarding diabetes as a predictor of greater hospital mortality 
in patients who undergo myocardial revascularization in 
conjunction with aortic valve replacement. In our study, we 
observed a greater prevalence of diabetes in the patient group 
that did not undergo associated procedures (34.8% versus 
12.5%, P=0.017). 
Although we used the preoperative Parsonnet risk score 
and not the EuroSCORE, we agree with Biancari et al.7 
that the Parsonnet score is the most relevant predictor of 
immediate clinical outcomes after CABG. In our study, 
the risk score for Group 2 patients was higher than that for 
Group 1 (33±8.33 versus 24.12±8.39, P<0.001) and had a 
significant impact on hospital mortality (P=0.002). 
In our study, a female gender did not directly influence 
hospital mortality. However, the percentage of females was 
greater in Group 2 (46.9% versus 39.5%, P=0.456).
Our findings may corroborate those of Doenst et al,11 
who indicated that female sex is a predictor of higher risk 
for postoperative stroke in patients who undergo concomitant 
coronary artery and valve procedures. In our study, we had 
a larger percentage of female patients in Group 2 than in 
Group 1 (46.9% versus 39.5%-P=0.456), and Group 2 had 
a greater occurrence of postoperative stroke (21.9% versus 
3.5%, P<0.001). 
The present study supports the results of Toumpoulis et 
al,12 who found respiratory insufficiency and postoperative 
infection to be isolated risk factors for late mortality in 
both sexes. In our study, postoperative breathing support 
and infection contributed to increased hospital mortality. 
The need for breathing support was greater in Group 2 
(53.2% versus 19.1%, P<0.001), which had a higher hospital 
Table 2 - Univariate analysis of study parameters
Variable P Value Variable P Value 
Height 0.066 Weight 0.193 
Body index mass 0.202 Angina functional class 0.087 
Angina type 0.353 Infarct preop 0.100 
Preop MI time 0.734 Preop stroke 0.614 
Heart Failure FC 0.195 Dyslipidemia 0.401 
Diabetes 0.017 Preop intra-aortic balloon 0.026 
Arterial Hypertension 0.294 Cardiac rhythm 0.101 
Preop creatinine 0.056 Peripheral atherosclerosis 0.172 
Preop cardiogenic shock 0.019 Preop endocarditis 0.001 
Carotid obstruction 0.865 Aortic calcification 0.207 
Preop LVEF 0.323 Left ventricle morphology 0.163 
Nº. of damaged arteries 0.000 Preop score (Parsonnet) 0.000 
Operative type 0.163 Postop MI 0.178 
CABG and assoc procedure 0.000 Extracorporeal uses 0.000 
Extracorporeal time 0.000 Aortic clamping 0.000 
Nº distal anastomoses 0.002 Graft type 0.000 
Postop breathing support 0.000 Postop  infection 0.002 
Postop low cardiac debit 0.526 Postop bleeding 0.220 
Reoperation for bleeding 0.754 Postop Heart FC 0.335 
Preop QOL 0.909 Postop QOL 0.050 
Postop stroke 0,000 Postop creatinine level 0.018
Hospital length of stay 0.461 Hospital mortality 0.002
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mortality. Infection was also greater in Group 2 (37% versus 
32.7%, P=0.002). 
Our findings concur with those of Mistiaen et al.13 who 
identified preoperative renal dysfunction as an isolated risk 
factor for mortality. Preoperative renal dysfunction was 
greater in Group 2 (3.1% versus 1.7%, P=0.056), but it did 
not influence hospital mortality in our study. We found a 
greater prevalence of postoperative renal dysfunction in 
Group 2 patients (28.1% versus 11.3%, P=0.018); this was 
related to the greater hospital mortality in that group.
Our findings support those of Mistiaen et al,13 who 
identified a history of treated endocarditis and left ventricular 
dysfunction as preoperative risk factors. For the treated 
endocarditis, a larger prevalence existed in Group 2 (15.6% 
versus 1.7%, P=0.001); this was significant because of the 
greater hospital mortality found in this group. Decreased left 
ventricular function was related to two variables identified as 
factors of preoperative risk: preoperative cardiogenic shock 
and preoperative need for the intra-aortic balloon pump. For 
cardiogenic shock, a greater prevalence was found in Group 
2 patients (22.6% versus 7.8%, P=0.019). There was a much 
greater prevalence of the use of the intra-aortic balloon pump 
in Group 2 than in Group 1 patients (18.8% versus 6.1%, 
P=0.026).
Our findings do not agree with those of Jones et al.1 who 
found that the use of a vein graft for the interventricular 
anterior branch of the left coronary artery in revascularization 
combined with aortic valve substitution improved survival. 
In our study, more patients who underwent associated 
procedures used vein grafts (76.7% group 2 versus 31.5% 
group 1), and this was linked to the greater mortality 
observed in Group 2 patients (P=0.002). However, our 
findings agree with the identification of the number of grafts 
performed as an inverse cause of reduced survival. We found 
that a smaller number of grafts were completed in Group 2 
than in Group 1 (2.0±0.80 versus 2.57±0.89, P=0.002), with 
Group 2 having a higher hospital mortality. 
The findings of the present study agree with those of 
Jensen et al.5 who found that CABG improves the quality 
of life regardless of whether it is performed with or without 
extracorporeal circulation. In our study, we confirmed 
improved quality of life in the postoperative period in 
both groups; however, quality of life scores were better in 
Group 1 than in Group 2 patients (55.6% versus 33.3%, 
P=0.050). 
We did not confirm the findings of Rankin et al,10 who 
showed that coronary artery disease was a risk factor for 
concomitant revascularization and valve surgery (odds 
ratio=1.58). In our study, the patient group with higher 
mortality had less severe coronary artery disease (2.06±0.71 
versus 2.59±0.67, P<0.001). 
Our findings confirm those of Reston et al.14 who 
reported that the frequency of renal dysfunction, stroke, and 
hospital mortality was less in patients operated on without 
extracorporeal circulation. In our study, in 98 of the 115 
patients operated on without extracorporeal circulation, 
we found a reduced prevalence of postoperative renal 
dysfunction (11.3% versus 28.1%, P=0.018) and of stroke 
(3.5% versus 21.9%, P<0.001) in Group 1 when compared 
to Group 2 that was related to the lower hospital mortality in 
that group (P=0.002). 
Our discoveries are in accord with those of Mack et al,15 
who found extracorporeal circulation to be an independent 
predictor of increased hospital mortality (P<0.001). In our 
study, the patients in the group that received associated 
procedures all needed extracorporeal circulation (100% 
versus 42.6%, P<0.001); this resulted in the greater mortality 
observed in that group (P=0.002). 
CONCLUSION
The performance of procedures associated with surgical 
myocardial revascularization in octogenarian patients 
produced a 45% increase in the risk of hospital mortality. 
The risk factors that contributed most to the deaths 
were: previous endocarditis, preoperative cardiogenic 
shock, hospital stay, postoperative creatinine levels, use 
of extracorporeal circulation, time of extracorporeal 
circulation, and need for prolonged respiratory support in 
the postoperative period.
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